Cases 1 - 10 of 150
INTRA-CELLULAR THERAPIES, INC. v. DR. REDDYS LABORATORIES, INC. et al
as 3:2024cv04314
Plaintiff:
INTRA-CELLULAR THERAPIES, INC.
Defendant:
DR. REDDYS LABORATORIES, INC. and DR. REDDYS LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
EAGLE PHARMACEUTICALS, INC. v. DR. REDDY'S LABORATORIES, LTD. et al
as 2:2024cv00637
Plaintiff:
EAGLE PHARMACEUTICALS, INC.
Defendant:
DR. REDDY'S LABORATORIES, LTD. and DR. REDDY'S LABORATORIES, INC
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
GENENTECH, INC. et al v. DR. REDDYS LABORATORIES, INC. et al
as 1:2023cv22485
Plaintiff:
GENENTECH, INC., HOFFMANN-LA ROCHE INC. and BIOGEN INC.
Defendant:
DR. REDDYS LABORATORIES, INC., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES LTD. and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
NOVO NORDISK INC. et al v. DR. REDDY'S LABORATORIES, LTD. et al
as 2:2023cv22112
Plaintiff:
NOVO NORDISK INC. and NOVO NORDISK A/S
Defendant:
DR. REDDY'S LABORATORIES, LTD. and DR. REDDY'S LABORATORIES, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GENENTECH, INC. et al v. DR. REDDYS LABORATORIES, INC. et al
as 2:2023cv22485
Plaintiff:
GENENTECH, INC., HOFFMANN-LA ROCHE INC. and BIOGEN INC.
Defendant:
DR. REDDYS LABORATORIES, INC., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES LTD. and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Galderma Laboratories, L.P. et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2023cv00711
Plaintiff:
Galderma Laboratories, L.P. and TCD Royalty Sub LP
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Horizon Therapeutics USA Inc. et al v. Dr. Reddys Laboratories, Ltd. et al
as 1:2023cv00623
Plaintiff:
Horizon Therapeutics USA Inc. and Horizon Therapeutics Ireland DAC
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Counter Claimant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI R&D MANAGEMENT CO., LTD. et al v. DR. REDDYS LABORATORIES, INC. et al
as 3:2022cv05950
Plaintiff:
EISAI R&D MANAGEMENT CO., LTD., EISAI CO., LTD. and EISAI INC.
Defendant:
DR. REDDYS LABORATORIES, INC. and DR. REDDYS LABORATORIES, LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH & LOMB INCORPORATED et al v. DR. REDDY'S LABORATORIES LTD. et al
as 3:2023cv03463
Plaintiff:
BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB IRELAND LIMITED and NICOX S.A.
Defendant:
DR. REDDY'S LABORATORIES LTD. and DR. REDDY'S LABORATORIES INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
